Literature DB >> 6428702

Regional brain catecholamine levels and the development of hypertension in the spontaneously hypertensive rat: the effect of 6-hydroxydopamine.

M van den Buuse, E R de Kloet, D H Versteeg, W de Jong.   

Abstract

To investigate the role of central catecholaminergic pathways in the development of hypertension in the spontaneously hypertensive rat (SHR) the effects of intracerebroventricular (i.c.v.) injections of 6-hydroxydopamine (6-OHDA) were compared with those of local injections near the main ascending noradrenergic pathways. The parameters studied were systolic blood pressure, heart rate and regional catecholamine concentrations in micropunched brain areas. I.c.v. treatment with 6-OHDA (three 200 micrograms injections) of young SHR attenuated the development of hypertension and caused widespread depletion of noradrenaline and to a lesser extent of dopamine and adrenaline. 6-OHDA-induced lesions of the dorsal and ventral noradrenergic bundles did not affect the rise in blood pressure but induced a depletion of forebrain noradrenaline comparable to that after the i.c.v. treatment. Dopamine and adrenaline levels were, however, not substantially affected. These results suggest that forebrain noradrenergic innervation may not be of major importance for the development of hypertension in the SHR.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428702     DOI: 10.1016/0006-8993(84)91090-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Lesions of the ventral noradrenergic bundle prevent the rise in blood pressure induced by social deprivation stress in the rat.

Authors:  S Montero; J A Fuentes; P Fernandez-Tome
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

2.  Changes in regional brain synaptosomal high affinity choline uptake during the development of hypertension in spontaneously hypertensive rats.

Authors:  G R Trimarchi; J J Buccafusco
Journal:  Neurochem Res       Date:  1987-03       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.